<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73690">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01675843</url>
  </required_header>
  <id_info>
    <org_study_id>AG/4/2010</org_study_id>
    <nct_id>NCT01675843</nct_id>
  </id_info>
  <brief_title>Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome</brief_title>
  <acronym>OSIPS</acronym>
  <official_title>Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <authority>Egypt: Ministry of Higher Education</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study null hypothethesis is: intrauterine insemination (IUI) does not improve pregnancy
      rates in women with polycystic ovary syndrome. Infertile women with pcos will receive
      gonadotropins for ovarian stimulation and then randomize to either IUI or timed intercourse
      (TI)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Live Birth Rate</measure>
    <time_frame>20 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>16 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>multiple pregnancy rate</measure>
    <time_frame>20 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Infertility</condition>
  <condition>Polycystic Ovarian Syndrome</condition>
  <condition>Intrauterine Insemination</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>controlled ovarian hyperstimulation (COH) and intrauterine insemination (IUI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Controlled ovarian hyperstimulation (COH)+ Timed Intercourse (TI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrauterine insemination (IUI)</intervention_name>
    <description>The male semen is obtained then processed by swim up technique and then introduced into the uterus by special catheter.</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>IUI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - women who failed to get pregnant after 6 ovulation induction cycles with clomiphene
        citrate (cc) alone, despite of being ovulating with cc, having patent Fallopian tubes as
        confirmed by hysterosalpingography and their partners had fertile semen parameters
        according to criteria of World Health Organization (WHO 2010)

        Exclusion Criteria:

        male factor infertility
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Gibreel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fertility Care Unit</name>
      <address>
        <city>Mansoura</city>
        <state>Eldakahlia</state>
        <zip>53111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 28, 2012</lastchanged_date>
  <firstreceived_date>August 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Ahmed Gibreel</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>PCOS</keyword>
  <keyword>IUI</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
